These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA.
Tryngolza: Package Insert / Prescribing Information / MOA
Feb 9, 2025 · Tryngolza package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.
Support Resources | TRYNGOLZA® (olezarsen) Injection
Access downloadable resources and watch videos to support your TRYNGOLZA® treatment journey. See Safety & Full Prescribing Information.
FDA Label for Tryngolza Injection, Solution Subcutaneous
4 days ago · Table of Contents Tryngolza Product Label The following document was submitted to the FDA by the labeler of this product Ionis Pharmaceuticals, Inc.. The document includes …
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information …
label - accessdata.fda.gov
Dosage modifications for TEVIMBRA for adverse reactions that require management different from these general guidelines are summarized in Table 2. Refer to the respective Prescribing …
Tryngolza | European Medicines Agency (EMA)
Jul 25, 2025 · Tryngolza can only be obtained with a prescription and is available as a solution for injection in prefilled pens. It is injected once a month under the skin in the abdomen (belly), the …
First FDA-Approved Medicine for FCS | TRYNGOLZA®
TRYNGOLZA® (olezarsen) is an FDA-approved treatment in adults with FCS as an adjunct to diet. See Safety & Full Prescribing Information.
The clinical efficacy of Tryngolza was assessed in a randomized, double-blind, placebo-controlled trial in 66 adults with genetically identified familial chylomicronemia syndrome. Inclusion …
TRYNGOLZA is a prescription medicine used along with diet to reduce triglycerides (fat in the blood) in the treatment of adults with a condition that keeps the body from breaking down fats …